Full Breakdown
Base Editing Reveals NANOG’s Essential Role in Early Human Embryos
6/26/2026, 11:04:26 AM
Precision Gene Editing of Human Embryos
The Loke Centre used base editing to knock out NANOG in surplus IVF embryos, preventing epiblast formation while preserving placental and yolk-sac lineages. Embryos were cultured up to six-and-a-half days before disposal.
Background & Context
CRISPR-Cas9 entered human-embryo research in 2015, sparking debate. A 2016 base-editor (David R. Liu, Broad) increased specificity. Niakan’s 2017 OCT4 work showed mouse-human differences; the 2026 Nature paper applies base editing to NANOG.
Key Researchers & Institutions
Lead investigators are Professor Kathy Niakan, Dr Oliver Bower, and Dr Katarina Harasimov. Collaborators include Monash University, the Broad Institute, the Francis Crick Institute, the MRC Laboratory of Molecular Biology, and partners Bourn Hall Clinic and Newcastle Fertility Centre.
Design & Findings
Base editing changed a single nucleotide in the ~3-billion-base-pair human genome, delivering disruption with fewer chromosomal errors than CRISPR-Cas9. Editing was mosaic—only some cells carried the edit—yet NANOG loss consistently blocked epiblast formation, unlike mouse embryos where Nanog loss also disrupts trophoblasts.
Official Statements & Regulatory Oversight
The work had an HFEA licence and Newcastle-North Tyneside Ethics Committee approval; UK law bans clinical germline editing.
Ethical Criticism
Earlier CRISPR embryo work drew criticism for using embryos some consider persons; using surplus IVF embryos mitigates but does not erase concerns about trait selection or disease-prevention editing.
Conflicting Reports & Gaps
The study reports mosaic outcomes and notes residual off-target changes remain incompletely quantified, underscoring the need for uniform editing and safety profiling.
Implications
Clarifying NANOG’s role may improve IVF implantation rates and, once safety hurdles are cleared, enable base-editor correction of monogenic diseases like cystic fibrosis or Huntington’s disease.
Verbatim Quotes
- “Our results indicate that the NANOG gene is critical for the development of pluripotent cells, the building blocks that are fundamentally important to human development.” — Professor Kathy Niakan
- “The precision of base editing is a major step from the previous generation of genome editing techniques. This allows us to study early human development with greater confidence,” — Dr Oliver Bower
- “By pinpointing how genes like NANOG control the development of pluripotent cells, we can make stem-cell systems for biomedical research more predictable and reliable.” — Dr Oliver Bower
- “We had predicted that the gene called NANOG would have a really important role in human development, given its importance in the development of mouse embryos. What we found was that NANOG functions somewhat differently in humans to mice, which means our assumptions about the role of this gene don’t transfer neatly across species,” — Dr Katarina Harasimov
What’s Next
Future work will aim for uniform base edits, expanded safety testing, and public-policy dialogue to define permissible clinical pathways for germline editing.
